Use of Memantine (Namenda) to Treat Autism, Compulsivity, and Impulsivity

Details for Australian Patent Application No. 2011235981 (hide)

Owner Mount Sinai School of Medicine

Inventors Hollander, Eric

Agent Wrays

Pub. Number AU-B-2011235981

Parent 2005286943

Filing date 12 October 2011

Wipo publication date 3 November 2011

Acceptance publication date 27 September 2012

International Classifications

A61K 31/13 - Amines, e.g. amantadine

Event Publications

27 October 2011 Complete Application Filed

3 November 2011 Application Open to Public Inspection

  Published as AU-B-2011235981

27 September 2012 Application Accepted

  Published as AU-B-2011235981

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011235982-Use of IL-6-Type Cytokines for Maturation of Oocytes

2011235980-Device for contactlessly controlling the surface profile of objects